Drugs / Sputnik Lite
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06057025 | Sep 2023 → Dec 2024 | COVID-19 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sputnik Lite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06057025 ↗ |
| Route | Intramuscular | “Single intramuscular injection” NCT06057025 ↗ |